Recombinant CD23 (Lumiliximab Biosimilar) anticorps
Aperçu rapide pour Recombinant CD23 (Lumiliximab Biosimilar) anticorps (ABIN7597802)
Antigène
Type d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
-
-
Expression System
- Mammalian cells
-
Fonction
- Research Grade Lumiliximab Biosimilar Antibody
-
Specificité
- Lymphocyte IgE receptor, C-type lectin domain family 4 member J, Low affinity immunoglobulin epsilon Fc receptor, CD23A, BLAST-2, Immunoglobulin E-binding factor, IGEBF, CD23, Fc-epsilon-RII, CLEC4J, FCE2, FCER2
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Pureté
- >95 % by SDS-PAGE.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.66 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Stock
- 4 °C,-20 °C,-80 °C
-
Stockage commentaire
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Date de péremption
- 12 months
-
-
- CD23 (Lumiliximab Biosimilar)
-
Autre désignation
- Lumiliximab Biosimilar
-
Classe de substances
- Biosimilar
-
Sujet
- Lymphocyte IgE receptor, C-type lectin domain family 4 member J, Low affinity immunoglobulin epsilon Fc receptor, CD23A, BLAST-2, Immunoglobulin E-binding factor, IGEBF, CD23, Fc-epsilon-RII, CLEC4J, FCE2, FCER2
-
UniProt
- P06734
-
Numéro CAS
- 357613-86-6
Antigène
-